Updates from The Motley Fool

Latest updates on Agenus, Inc. from Fool.com.


Stock Performance

AGEN vs. S&P 500 | 2 Year Performance
AGEN 1-Day Stock Chart
AGEN 5-Day Stock Chart
AGEN 1-Month Stock Chart
AGEN 3-Month Stock Chart
AGEN 6-Month Stock Chart
AGEN 1-Year Stock Chart
AGEN 2-Year Stock Chart
AGEN 5-Year Stock Chart
View Interactive AGEN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Agenus, Inc..
Current Price: $3.55
Prev Close: $3.84
Open: $3.85
Bid: $3.56
Ask: $3.57
Day's Range: $3.55 - $3.96
52wk Range: $2.61 - $10.16
Volume: 799,060
Avg Vol 1,134,140
Market Cap: $300.49M
P/E (ttm): -3.15
EPS (ttm): -$1.13
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Agenus, Inc..
CAPS Rating 3 out of 5
 
204 Outperform
83 Underperform
CAPS All Stars
 
31 Outperform
33 Underperform

How do you think Agenus, Inc. will perform against the market?



You pick for Agenus, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Garo H. Armen, CEO

56% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Agenus, Inc..

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers